Apotea (ST:APOTEA) — Market Cap & Net Worth
Market Cap & Net Worth: Apotea (APOTEA)
Apotea (ST:APOTEA) has a market capitalization of $830.46 Million (Skr7.72 Billion) as of August 25, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #9792 globally and #160 in its home market, demonstrating a 1.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Apotea's stock price Skr74.15 by its total outstanding shares 104070966 (104.07 Million). Check today's stock price for Apotea for real-time trading data and today's change.
Apotea Market Cap History: 2024 to 2026
Apotea's market capitalization history from 2024 to 2026. Data shows change from $239.45 Million to $830.46 Million (-7.05% CAGR).
Apotea Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Apotea's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Apotea (APOTEA) net assets to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
0.14x
Apotea's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.52x
Apotea's market cap is 4.52 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $239.45 Million | $6.54 Billion | $214.90 Million | 0.04x | 1.11x |
| 2025 | $1.03 Billion | $7.20 Billion | $228.70 Million | 0.14x | 4.52x |
Competitor Companies of APOTEA by Market Capitalization
Companies near Apotea in the global market cap rankings as of August 25, 2026. Also see cash flow conversion of Apotea for how efficiently the company converts equity into cash flow.
Key companies related to Apotea by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1727 globally with a market cap of $14.12 Billion USD ( €12.08 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2211 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2570 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3102 globally with a market cap of $6.32 Billion USD ( R$32.23 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1727 | JD HEALTH INTL LTD | F:8ZN | $14.12 Billion | €4.17 |
| #2211 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2570 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3102 | Raia Drogasil S.A | SA:RADL3 | $6.32 Billion | R$18.43 |
Apotea Historical Marketcap From 2024 to 2026
Between 2024 and today, Apotea's market cap moved from $239.45 Million to $ 830.46 Million, with a yearly change of -7.05%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr830.46 Million | -19.59% |
| 2025 | Skr1.03 Billion | +331.34% |
| 2024 | Skr239.45 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 24th, 2026 the market cap of Apotea was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $830.46 Million USD |
| MoneyControl | $830.46 Million USD |
| MarketWatch | $830.46 Million USD |
| marketcap.company | $830.46 Million USD |
| Reuters | $830.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food … Read more